Delivery Order SPE2DB20D1050-SPE2DB25FH89A
- Not listed
- The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a $5,529.77 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and has an ultimate completion date of August 6, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 31, 2025. This firm fixed-price, competitively awarded delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injectors with a ceiling value of $4,984.68. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,063.97 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order is scheduled for ultimate completion by August 20, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,247.39 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing with a completion date of July 31, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a contract value of $15,251.60. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 12, 2025, with the place of performance located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors with a ceiling value of $2,287.74. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 26, 2025, and no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,146.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was awarded without set-aside designation through open competition, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract is performed at AmerisourceBergen's...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH89ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,225.17 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on September 8, 2025, with a completion date of September 9, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains significant federal contracting relationships with the Defense Logistics Agency and serves critical medical procurement needs for military and veteran healthcare systems. This Zepbound delivery order represents one of numerous pharmaceutical product deliveries under the company's federal contract portfolio, which historically encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to fulfill federal requirements through open competition, combined with its substantial indefinite delivery vehicle, positions it as a key supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/8/25 |